APA Alıntı

Warrilow, A. G. S., Hull, C. M., Parker, J. E., Garvey, E. P., Hoekstra, W. J., Moore, W. R., . . . Kelly, S. L. (2014). The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme. Antimicrob Agents Chemother.

Chicago Stili Alıntı

Warrilow, A. G. S., C. M. Hull, J. E. Parker, E. P. Garvey, W. J. Hoekstra, W. R. Moore, R. J. Schotzinger, D. E. Kelly, ve S. L. Kelly. "The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida Albicans CYP51 but Fails To Bind the Human Enzyme." Antimicrob Agents Chemother 2014.

MLA Alıntı

Warrilow, A. G. S., et al. "The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida Albicans CYP51 but Fails To Bind the Human Enzyme." Antimicrob Agents Chemother 2014.